- Home
- LGCB vs VRAX Comparison
LGCB vs VRAX Comparison
Compare LGCB & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- VRAX
- Stock Information
- Founded
- LGCB 2011
- VRAX 2013
- Country
- LGCB Japan
- VRAX United Kingdom
- Employees
- LGCB N/A
- VRAX N/A
- Industry
- LGCB
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LGCB
- VRAX Health Care
- Exchange
- LGCB Nasdaq
- VRAX Nasdaq
- Market Cap
- LGCB 8.4M
- VRAX 7.3M
- IPO Year
- LGCB 2023
- VRAX 2022
- Fundamental
- Price
- LGCB $0.22
- VRAX $1.49
- Analyst Decision
- LGCB
- VRAX
- Analyst Count
- LGCB 0
- VRAX 0
- Target Price
- LGCB N/A
- VRAX N/A
- AVG Volume (30 Days)
- LGCB 389.9K
- VRAX 239.6K
- Earning Date
- LGCB 03-18-2025
- VRAX 02-05-2025
- Dividend Yield
- LGCB N/A
- VRAX N/A
- EPS Growth
- LGCB N/A
- VRAX N/A
- EPS
- LGCB N/A
- VRAX N/A
- Revenue
- LGCB $10,289,681.00
- VRAX $84,872.00
- Revenue This Year
- LGCB N/A
- VRAX $5,169.18
- Revenue Next Year
- LGCB N/A
- VRAX $66.97
- P/E Ratio
- LGCB N/A
- VRAX N/A
- Revenue Growth
- LGCB N/A
- VRAX 7.03
- 52 Week Low
- LGCB $0.17
- VRAX $0.60
- 52 Week High
- LGCB $5.71
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- LGCB 41.77
- VRAX 41.77
- Support Level
- LGCB $0.22
- VRAX $1.22
- Resistance Level
- LGCB $0.25
- VRAX $1.84
- Average True Range (ATR)
- LGCB 0.03
- VRAX 0.17
- MACD
- LGCB -0.00
- VRAX -0.01
- Stochastic Oscillator
- LGCB 16.48
- VRAX 38.36
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.